Advocacy matters.
Youth leadership matters.
Community matters.
CLICK HERE to read the joint guidance notice from the WFH, the EAHAD, the EHC, and U.S. National Hemophilia Foundation with regards to the COVID-19 vaccine.
The Association of Hemophilia Clinic Directors of Canada (AHCDC) has issued a message to address the most frequent questions asked with regards to the COVID-19 vaccine and bleeding disorders: CLICK HERE.
Special Additional Call for Applications - CHS Research programs
The Canadian Hemophilia Society (CHS) is pleased to put out a special call for applications for two of its research programs for the 2021-2022 grant period: the CHS/Novo Nordisk Psychosocial Research Program and the CHS – Bayer – ADVANCE Canada Research Program.
Deadline: 5:00 PM January 18, 2021 (Grant period of April 2021 to March 2022)

